Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS): A Pragmatic Randomized Trial to Evaluate Clinician Outreach to Reduce Upper Gastrointestinal Bleeding Risk in Patients Taking Warfarin and Antiplatelet Therapy

NCT05563714 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT05563714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05563714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS): A Pragmatic Randomized Trial to Evaluate Clinician Outreach to Reduce Upper Gastrointestinal Bleeding Risk in Patients Taking Warfarin and Antiplatelet Therapy
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Completed
Start date
October 5, 2022
Completion date
January 4, 2023
Enrollment
341 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-induced bleeding, peptic ulcer hemorrhage, upper gastrointestinal bleeding